Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Praziquantel dose-finding and pharmacokinetic study in children with schistosomiasis
ISRCTN15280205Phase 2Completed
- Sponsor
- European Research Council
- Start
- Nov 2014
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of praziquantel in schistosomiasis (4 arms), sponsored by European Research Council. Primary endpoint: Cure rate. Started Nov 2014; status: completed.
02
Drugs
praziquantel
03
Conditions
schistosomiasis
Beyond the preview
Go deeper on ISRCTN15280205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15280205.